Strategic Global Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.16M Sell
10,751
-280
-3% -$143K 0.83% 43
2025
Q4
$6.2M Buy
11,031
+7,257
+192% +$4.12M 0.96% 31
2025
Q3
$1.94M Sell
3,774
-175
-4% -$76.4K 0.29% 87
2025
Q2
$1.24M Buy
3,949
+234
+6% +$70.3K 0.2% 100
2025
Q1
$1.13M Sell
3,715
-100
-3% -$33.6K 0.22% 103
2024
Q4
$1.27M Buy
3,815
+309
+9% +$105K 0.23% 89
2024
Q3
$1.17M Sell
3,506
-31
-0.9% -$11.8K 0.23% 99
2024
Q2
$1.46M Buy
3,537
+68
+2% +$26.9K 0.3% 83
2024
Q1
$1.4M Sell
3,469
-101
-3% -$35.5K 0.3% 87
2023
Q4
$1.09M Buy
+3,570
New +$964K 0.25% 105

Other funds holding MEDP

Strategic Global Advisors's MEDP Position: Q1 2026 in Review

Strategic Global Advisors reduced its Medpace (MEDP) stake by 2.5% in Q1 2026, selling an estimated $143K and leaving 10,751 shares worth $5.16M. The position accounts for 0.83% of the portfolio, ranked #43.

Strategic Global Advisors first reported a position in MEDP in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.2M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Strategic Global Advisors held 10,751 shares of Medpace worth $5.16M as of Q1 2026.
  • Strategic Global Advisors sold 280 Medpace shares in Q1 2026, an estimated $143K.
  • Medpace made up 0.83% of Strategic Global Advisors's portfolio in Q1 2026, its #43 holding.
  • Strategic Global Advisors first reported a position in Medpace in Q4 2023 and has held it in 10 quarters since.
  • Strategic Global Advisors's Medpace position peaked at $6.2M in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Strategic Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.